First Affiliated Hospital of Sichuan Medical University
In research, First Affiliated Hospital of Sichuan Medical University stands highest in Life Sciences (#2,185 of 7,800 worldwide), Medicine (#4,050 of 10,443 worldwide) and Health Sciences (#4,772 of 11,982 worldwide), 2022–2025. Relative to its size it is most specialised in Oncology — Oncology is 6.2× its share of world research.
- World rank, 2022–2025
- #5,287 of 28,054 · #10,448 all time
- Rank in China
- #1,148 of 3,058
- Research works
- 1.6k ▼ 56% vs 2013–17
- Citations
- 15k 9.4 per fractional work
- Top-10% rate
- 27.4% record average 16.5%
- Open access
- 31% world 28%
What is First Affiliated Hospital of Sichuan Medical University known for in research?
The fields where it stands highest, 2022–2025, ranked among every institution above the floor in each field.
| Field | World rank | Where that sits | Top-10% rate | Works | All time |
|---|---|---|---|---|---|
| Life SciencesDomain | #2,185 of 7,800 | 26.6% | 101 | #4990 | |
| MedicineField | #4,050 of 10,443 | 26.6% | 167 | #5897 | |
| Health SciencesDomain | #4,772 of 11,982 | 27.6% | 177 | #6777 | |
| Biochemistry, Genetics and Molecular BiologyField | #1,976 of 3,579 | 26.3% | 68 | #4829 |
Each strip is that field’s whole ranked pool, with the notch where First Affiliated Hospital of Sichuan Medical University sits in it, in the colour of the band that rank falls in. The track under the rate is the rate itself: it carries no world mark, because the world rate differs by field (from about 6% to 21% in this record).
Which of those standings moved
The same fields on both windows: where it stood over the whole record, and where it stands in 2022–2025. The distance is the story, and it is the one thing the two rank columns above cannot show.
- Life Sciences#4,990 #2,185
- Medicine#5,897 #4,050
- Health Sciences#6,777 #4,772
- Biochemistry, Genetics and Molecular Biology#4,829 #1,976
A dot further right is a better standing. Fields it was not ranked in over the whole record are left out.
What does First Affiliated Hospital of Sichuan Medical University specialise in?
Where its research is concentrated relative to its size: Oncology takes 6.2× the share of its output that it takes of world research.
- OncologySubfield · 22.8 works6.2×
Location quotient, a volume reading rather than an impact one. It surfaces small, lopsided specialities.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Biochemistry, Genetics and Molecular Biology, 3.9×. Every wedge is a field page.
- Biochemistry, Genetics and Molecular Biology 3.9×
- Immunology and Microbiology 2.9×
- Pharmacology, Toxicology and Pharmaceutics 2.8×
- Medicine 2.6×
- Nursing 1.8×
- Neuroscience 1.6×
- Chemistry 1.2×
- Decision Sciences 0.8×
- Dentistry 0.8×
- Agricultural and Biological Sciences 0.8×
- Health Professions 0.6×
- Materials Science 0.5×
- Economics, Econometrics and Finance 0.3×
- Engineering 0.3×
- Psychology 0.3×
- Veterinary 0.3×
- Computer Science 0.2×
- Environmental Science 0.2×
- Chemical Engineering 0.2×
- Energy 0.1×
- Social Sciences 0.1×
- Earth and Planetary Sciences 0.1×
- Business, Management and Accounting 0.1×
- Arts and Humanities 0.0×
- Mathematics 0.0×
- Physics and Astronomy 0.0×
Who are the top researchers at First Affiliated Hospital of Sichuan Medical University?
Ranked on the composite score, Mingyong Wang lead among researchers whose main affiliation is First Affiliated Hospital of Sichuan Medical University.
- 1 Mingyong Wang China · #1,240,581 worldwide 14 citations · 16 works
Which keywords describe research at First Affiliated Hospital of Sichuan Medical University?
By fractional works in 2022–2025, weighted toward what it does more of than the world: Inflammation, Cancer, Tumor Microenvironment, Oxidative Stress, Angiogenesis, Metabolic Syndrome, Cancer Therapy and PET Imaging.
- Oxygen Sensing
- Macrophages
- Matrix Metalloproteinases
- Hepatocellular Carcinoma
- Extracellular Matrix
- Cancer Treatment
- Immunity
- Fibroblast Activation Protein
- Chemotherapy
- Management
- Stromal Cells
- Obesity
- Insulin Resistance
- Metastasis
- Gene Expression
- Immunotherapy
- Angiogenesis
- Metabolic Syndrome
- Epidemiology
- Cancer
- Inflammation
- Tumor Microenvironment
- Oxidative Stress
- Cardiovascular Disease
- Cancer Therapy
- PET Imaging
- Metabolism
- Biomarkers
- Diabetes
- Cancer Progression
- Immunosuppression
- Apoptosis
- Clinical Practice Guidelines
- N-terminal Acetylation
- Cell Death
- Atherosclerosis
- Targeted Therapy
- Tumor Targeting
- Cell Signaling
- HIF-1
Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Inflammation34▲ 5.0×70 topics
- Cancer29▲ 6.5×46 topics
- Tumor Microenvironment22▲ 15×8 topics
- Epidemiology22▲ 1.72×76 topics
- Oxidative Stress22▲ 4.2×45 topics
- Metabolic Syndrome16▲ 5.8×22 topics
- Cardiovascular Disease15▲ 4.1×31 topics
- Angiogenesis15▲ 14×14 topics
- Cancer Therapy13▲ 7.1×14 topics
- Immunotherapy12▲ 5.0×14 topics
- PET Imaging11▲ 20×4 topics
- Gene Expression10▲ 5.0×14 topics
- Metabolism10▲ 5.9×24 topics
- Metastasis10▲ 8.6×12 topics
- Biomarkers9▲ 3.9×14 topics
- Insulin Resistance9▲ 5.8×9 topics
- Diabetes8▲ 5.1×18 topics
- Obesity8▲ 3.3×18 topics
- Cancer Progression8▲ 13×7 topics
- Stromal Cells8▲ 29×2 topics
- Immunosuppression8▲ 25×3 topics
- Management8▲ 2.9×16 topics
- Apoptosis7▲ 7.3×18 topics
- Chemotherapy7▲ 3.2×21 topics
- Clinical Practice Guidelines7▲ 4.0×12 topics
- Fibroblast Activation Protein7▲ 49×1 topic
- N-terminal Acetylation7▲ 49×1 topic
- Immunity7▲ 5.3×9 topics
- Cell Death7▲ 9.1×6 topics
- Cancer Treatment6▲ 8.4×9 topics
- Atherosclerosis6▲ 5.9×12 topics
- Extracellular Matrix5▲ 9.3×7 topics
- Targeted Therapy5▲ 7.4×4 topics
- Hepatocellular Carcinoma5▲ 7.2×3 topics
- Tumor Targeting5▲ 8.5×3 topics
- Matrix Metalloproteinases5▲ 11×4 topics
- Cell Signaling5▲ 9.2×10 topics
- Macrophages5▲ 8.3×7 topics
- HIF-14▲ 23×1 topic
- Oxygen Sensing4▲ 12×2 topics
Which research topics does First Affiliated Hospital of Sichuan Medical University publish most on?
By volume in 2022–2025: Peptidase Inhibition and Analysis, Cancer, Hypoxia, and Metabolism, Protease and Inhibitor Mechanisms and Ferroptosis and cancer prognosis.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Peptidase Inhibition and Analysis Oncology 7 works
- 2 Cancer, Hypoxia, and Metabolism Cancer Research 4 works
- 3 Protease and Inhibitor Mechanisms Cancer Research 4 works
- 4 Ferroptosis and cancer prognosis Pulmonary and Respiratory Medicine 4 works
- 5 Radiopharmaceutical Chemistry and Applications Radiology, Nuclear Medicine and Imaging 4 works
- 6 Cancer Immunotherapy and Biomarkers Oncology 3 works
- 7 Liver Disease Diagnosis and Treatment Epidemiology 3 works
- 8 Fermentation and Sensory Analysis Food Science 3 works
- 9 RNA modifications and cancer Molecular Biology 3 works
- 10 Cancer-related molecular mechanisms research Cancer Research 3 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has First Affiliated Hospital of Sichuan Medical University's research output changed?
Output in 2018–2022 was 56% lower than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Luzhou
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.